Brian Jamieson

699 total citations
26 papers, 425 citations indexed

About

Brian Jamieson is a scholar working on Hematology, Epidemiology and Genetics. According to data from OpenAlex, Brian Jamieson has authored 26 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Epidemiology and 7 papers in Genetics. Recurrent topics in Brian Jamieson's work include Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (10 papers) and Pneumonia and Respiratory Infections (8 papers). Brian Jamieson is often cited by papers focused on Platelet Disorders and Treatments (13 papers), Blood groups and transfusion (10 papers) and Pneumonia and Respiratory Infections (8 papers). Brian Jamieson collaborates with scholars based in United States, Czechia and Serbia. Brian Jamieson's co-authors include Prabhavathi Fernandes, Jiřı́ Mayer, Katarzyna Krawczyk, Wei Tian, Lee F. Allen, Wojciech Jurczak, Krzysztof Chojnowski, David Oldach, Anita Das and Edward R. Mariano and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brian Jamieson

22 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Jamieson United States 9 178 139 67 56 54 26 425
M. Cesana Italy 12 76 0.4× 121 0.9× 14 0.2× 109 1.9× 63 1.2× 28 332
Veronika Kohlbrenner United States 12 28 0.2× 111 0.8× 10 0.1× 26 0.5× 11 0.2× 18 548
J.L. Pellegrin France 12 50 0.3× 101 0.7× 6 0.1× 22 0.4× 10 0.2× 27 463
Rinzō Soejima Japan 12 18 0.1× 135 1.0× 85 1.3× 92 1.6× 3 0.1× 55 428
Andrés Sánchez‐Salinas Spain 7 27 0.2× 109 0.8× 4 0.1× 82 1.5× 13 0.2× 21 579
Nobumasa Aoki Japan 10 10 0.1× 200 1.4× 10 0.1× 41 0.7× 8 0.1× 25 443
So Young Kang South Korea 12 17 0.1× 202 1.5× 39 0.6× 7 0.1× 7 0.1× 35 398
Ken Flora United States 9 17 0.1× 129 0.9× 9 0.1× 19 0.3× 15 0.3× 11 433
Brian M. Wicklund United States 12 148 0.8× 67 0.5× 4 0.1× 5 0.1× 36 0.7× 23 391
Nour Abidi Belgium 7 72 0.4× 98 0.7× 2 0.0× 18 0.3× 102 1.9× 8 334

Countries citing papers authored by Brian Jamieson

Since Specialization
Citations

This map shows the geographic impact of Brian Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Jamieson more than expected).

Fields of papers citing papers by Brian Jamieson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Jamieson. The network helps show where Brian Jamieson may publish in the future.

Co-authorship network of co-authors of Brian Jamieson

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Jamieson. A scholar is included among the top collaborators of Brian Jamieson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Jamieson. Brian Jamieson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Hiroki, Masaki Iino, Shugo Kowata, et al.. (2025). A phase 3 study of the efficacy and safety of avatrombopag in Japanese adults with chronic immune thrombocytopenia. International Journal of Hematology. 122(4). 521–532.
2.
Grace, Rachael F., Göksel Leblebisatan, Yeşim Aydınok, et al.. (2025). Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study. The Lancet Haematology. 12(7). e494–e504.
3.
Tarantino, Michael D., et al.. (2025). Safety, efficacy, and treatment satisfaction in adults with ITP who switched to avatrombopag from another TPO-RA. Blood Advances. 9(11). 2733–2743.
4.
5.
6.
7.
8.
Tarantino, Michael D., et al.. (2020). Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag. Blood. 136(Supplement 1). 23–24. 3 indexed citations
9.
10.
11.
Jurczak, Wojciech, Krzysztof Chojnowski, Jiřı́ Mayer, et al.. (2018). Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. British Journal of Haematology. 183(3). 479–490. 152 indexed citations
12.
Salerno, Sara, Andrea N. Edginton, Michael Cohen‐Wolkowiez, et al.. (2017). Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid. CPT Pharmacometrics & Systems Pharmacology. 6(12). 814–822. 11 indexed citations
13.
14.
Darpö, Börje, Philip T. Sager, Prabhavathi Fernandes, et al.. (2016). Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects. Journal of Antimicrobial Chemotherapy. 72(2). 515–521. 11 indexed citations
15.
Hook, Edward W., Matthew R. Golden, Brian Jamieson, et al.. (2015). A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. Clinical Infectious Diseases. 61(7). 1043–1048. 50 indexed citations
16.
Oldach, David, Hristo Metev, Analía Mykietiuk, et al.. (2015). Characterization of Mycoplasma pneumoniae Infection and Outcomes in the SOLITAIRE-Oral, Global Phase 3 Clinical Trial for Solithromycin. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
17.
Jamieson, Brian, et al.. (2015). Safety and Pharmacokinetics of Solithromycin in Subjects with Hepatic Impairment. Antimicrobial Agents and Chemotherapy. 59(8). 4379–4386. 20 indexed citations
18.
19.
Fernandes, Prabhavathi, et al.. (2011). Solithromycin. Drugs of the Future. 36(10). 751–751. 11 indexed citations
20.
Jamieson, Brian & Edward R. Mariano. (2007). Thoracic and lumbar paravertebral blocks for outpatient lithotripsy. Journal of Clinical Anesthesia. 19(2). 149–151. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Cesana Breakdown of academic impact, for papers by Veronika Kohlbrenner Breakdown of academic impact, for papers by J.L. Pellegrin Breakdown of academic impact, for papers by Rinzō Soejima Breakdown of academic impact, for papers by Andrés Sánchez‐Salinas Breakdown of academic impact, for papers by Nobumasa Aoki Breakdown of academic impact, for papers by So Young Kang Breakdown of academic impact, for papers by Ken Flora Breakdown of academic impact, for papers by Brian M. Wicklund Breakdown of academic impact, for papers by Nour Abidi
Rankless by CCL
2026